bpc-157 human clinical trials gut healing for Injury Recovery and Health: A Regenerative Peptide with Strong Potential BPC-157 is being marketed as
Description
BPC-157 is characterised through the nitric oxide system and FAK-paxillin signalling
Psychoneuroendocrinology (1995) This controlled human study tested whether DSIP modulates the hypothalamic-pituitary-adrenal (HPA) stress axis
to help with that
Warning: Keep out of reach of children
Dose: 0.25-0.5 mg daily (250-500 mcg) Frequency: Once daily for maintenance
